id	sid	eid	entity	type
admet-1437	1	1	253	CARDINAL
admet-1437	1	2	admet & dmpk 10(4	ORG
admet-1437	1	3	2022	CARDINAL
admet-1437	1	4	253	CARDINAL
admet-1437	1	5	issn	PERSON
admet-1437	1	6	1848-7718	DATE
admet-1437	1	7	development1 bastian bonhoeffer	PERSON
admet-1437	1	8	andreas kordikowski	PERSON
admet-1437	1	9	edgar john	PERSON
admet-1437	1	10	michael juhnke*	PERSON
admet-1437	1	11	novartis pharma ag	ORG
admet-1437	1	12	1	CARDINAL
admet-1437	1	13	4056	CARDINAL
admet-1437	1	14	basel	GPE
admet-1437	1	15	switzerland	GPE
admet-1437	1	16	michael.juhnke@gmx.ch	PERSON
admet-1437	1	17	june 30	DATE
admet-1437	1	18	2022	CARDINAL
admet-1437	1	19	august 02	DATE
admet-1437	1	20	2022	CARDINAL
admet-1437	1	21	august 04	DATE
admet-1437	1	22	2022	CARDINAL
admet-1437	3	1	noyes-whitney / nernst-brunner	ORG
admet-1437	8	1	2022	CARDINAL
admet-1437	11	1	the last three decades	DATE
admet-1437	11	2	1	CARDINAL
admet-1437	12	1	8	CARDINAL
admet-1437	13	1	9	CARDINAL
admet-1437	14	1	1	CARDINAL
admet-1437	14	2	konstantin tsinman	PERSON
admet-1437	15	1	bonhoeffer et al. admet	PERSON
admet-1437	15	2	2022	CARDINAL
admet-1437	15	3	253	CARDINAL
admet-1437	15	4	8,11	CARDINAL
admet-1437	16	1	12	CARDINAL
admet-1437	17	1	15-19	CARDINAL
admet-1437	20	1	between about 150 to 300	CARDINAL
admet-1437	21	1	20,21	CARDINAL
admet-1437	23	1	11,22-30	CARDINAL
admet-1437	27	1	11,22,24-28	CARDINAL
admet-1437	30	1	31	CARDINAL
admet-1437	31	1	seconds	TIME
admet-1437	33	1	8	CARDINAL
admet-1437	34	1	second	ORDINAL
admet-1437	34	2	29,35,40,41	CARDINAL
admet-1437	35	1	42	CARDINAL
admet-1437	37	1	23,27,29,32	CARDINAL
admet-1437	40	1	37,39	CARDINAL
admet-1437	41	1	8,43	CARDINAL
admet-1437	43	1	2022	CARDINAL
admet-1437	43	2	253	CARDINAL
admet-1437	43	3	255	CARDINAL
admet-1437	43	4	up to about 15 to 20 %	CARDINAL
admet-1437	43	5	about 150	CARDINAL
admet-1437	43	6	8,43	CARDINAL
admet-1437	44	1	8	CARDINAL
admet-1437	46	1	50	CARDINAL
admet-1437	46	2	8	CARDINAL
admet-1437	47	1	47	CARDINAL
admet-1437	48	1	30,53	CARDINAL
admet-1437	49	1	liu et al	PERSON
admet-1437	49	2	1300	CARDINAL
admet-1437	49	3	560	CARDINAL
admet-1437	49	4	340	CARDINAL
admet-1437	49	5	30	CARDINAL
admet-1437	50	1	ely et al	PERSON
admet-1437	51	1	53	CARDINAL
admet-1437	52	1	johnson	PERSON
admet-1437	52	2	54	CARDINAL
admet-1437	54	1	6	CARDINAL
admet-1437	54	2	55	CARDINAL
admet-1437	58	1	the noyes-whitney / nernst-brunner	ORG
admet-1437	60	1	novartis pharma ag	ORG
admet-1437	61	1	500 g	QUANTITY
admet-1437	61	2	180 °	QUANTITY
admet-1437	61	3	below 0.1 mg/ml	QUANTITY
admet-1437	62	1	15-19	CARDINAL
admet-1437	64	1	bonhoeffer et al	PERSON
admet-1437	64	2	2022	CARDINAL
admet-1437	64	3	253	CARDINAL
admet-1437	65	1	25 %	PERCENT
admet-1437	65	2	4 %	PERCENT
admet-1437	65	3	71 %	PERCENT
admet-1437	66	1	100	CARDINAL
admet-1437	66	2	mill labstar	PERSON
admet-1437	66	3	100	CARDINAL
admet-1437	66	4	300 μm	QUANTITY
admet-1437	67	1	100	CARDINAL
admet-1437	67	2	015	CARDINAL
admet-1437	67	3	hiroshima metal & machinery	ORG
admet-1437	67	4	30 μm	QUANTITY
admet-1437	68	1	12	CARDINAL
admet-1437	68	2	14 m	QUANTITY
admet-1437	68	3	up to 8 hours	TIME
admet-1437	69	1	between 20 to 25 °	CARDINAL
admet-1437	70	1	dsa100	GPE
admet-1437	70	2	neuronic	ORG
admet-1437	70	3	580	CARDINAL
admet-1437	71	1	owens	PERSON
admet-1437	72	1	56,57	CARDINAL
admet-1437	73	1	15	CARDINAL
admet-1437	73	2	dorris	PERSON
admet-1437	74	1	58	CARDINAL
admet-1437	76	1	10 %	PERCENT
admet-1437	76	2	20	CARDINAL
admet-1437	77	1	59	CARDINAL
admet-1437	78	1	zs	ORG
admet-1437	78	2	0.1 mm	QUANTITY
admet-1437	79	1	60	CARDINAL
admet-1437	80	1	61	CARDINAL
admet-1437	81	1	q3	ORG
admet-1437	82	1	300	CARDINAL
admet-1437	82	2	carl zeiss	PERSON
admet-1437	83	1	5	CARDINAL
admet-1437	85	1	1 l	DATE
admet-1437	85	2	0.01	CARDINAL
admet-1437	85	3	2	CARDINAL
admet-1437	85	4	3	CARDINAL
admet-1437	85	5	4.5	QUANTITY
admet-1437	86	1	22 °	QUANTITY
admet-1437	86	2	24	CARDINAL
admet-1437	87	1	three	CARDINAL
admet-1437	87	2	2022	CARDINAL
admet-1437	87	3	253	CARDINAL
admet-1437	87	4	257	CARDINAL
admet-1437	87	5	one	CARDINAL
admet-1437	88	1	two	CARDINAL
admet-1437	88	2	beckmann coulter optima	ORG
admet-1437	88	3	max	PERSON
admet-1437	89	1	first	ORDINAL
admet-1437	89	2	22 °	QUANTITY
admet-1437	90	1	541’000-fold	CARDINAL
admet-1437	90	2	10 min	TIME
admet-1437	90	3	22 °	QUANTITY
admet-1437	94	1	1290	CARDINAL
admet-1437	94	2	better than 0.3 %	PERCENT
admet-1437	97	1	between 2° to 40° 2θ	QUANTITY
admet-1437	97	2	0.017°	QUANTITY
admet-1437	98	1	40	CARDINAL
admet-1437	98	2	40 ma	QUANTITY
admet-1437	99	1	10.00 ± 0.05	MONEY
admet-1437	100	1	2	CARDINAL
admet-1437	101	1	1.7 °	QUANTITY
admet-1437	103	1	0.7 mm	QUANTITY
admet-1437	103	2	80	CARDINAL
admet-1437	103	3	100 mm	QUANTITY
admet-1437	104	1	0.5 mm	QUANTITY
admet-1437	106	1	2	CARDINAL
admet-1437	106	2	0.1 °	QUANTITY
admet-1437	107	1	the noyes-whitney / nernst-brunner	ORG
admet-1437	107	2	62,63	CARDINAL
admet-1437	109	1	1	CARDINAL
admet-1437	111	1	6∙𝜋∙𝜂∙𝑅0	CARDINAL
admet-1437	111	2	2	CARDINAL
admet-1437	111	3	kb	ORG
admet-1437	113	1	bonhoeffer et al. admet	PERSON
admet-1437	113	2	2022	CARDINAL
admet-1437	113	3	253	CARDINAL
admet-1437	113	4	258	CARDINAL
admet-1437	114	1	64	CARDINAL
admet-1437	115	1	zero	CARDINAL
admet-1437	115	2	65,66	CARDINAL
admet-1437	117	1	65,67	CARDINAL
admet-1437	117	2	2	CARDINAL
admet-1437	117	3	3	CARDINAL
admet-1437	117	4	72	CARDINAL
admet-1437	117	5	∙	ORG
admet-1437	117	6	4	CARDINAL
admet-1437	117	7	sapp	ORG
admet-1437	118	1	4	CARDINAL
admet-1437	119	1	8,43	CARDINAL
admet-1437	120	1	1	CARDINAL
admet-1437	120	2	3	CARDINAL
admet-1437	120	3	4	CARDINAL
admet-1437	120	4	1 µm	CARDINAL
admet-1437	124	1	one	CARDINAL
admet-1437	125	1	1 µm	CARDINAL
admet-1437	128	1	q3	ORG
admet-1437	129	1	999	CARDINAL
admet-1437	129	2	q3	ORG
admet-1437	131	1	2022	CARDINAL
admet-1437	131	2	253	CARDINAL
admet-1437	131	3	259	CARDINAL
admet-1437	131	4	1	CARDINAL
admet-1437	131	5	noyes-whitney / nernst-brunner	ORG
admet-1437	131	6	1μm	ORDINAL
admet-1437	131	7	s0	ORG
admet-1437	131	8	1	CARDINAL
admet-1437	131	9	1 µm	CARDINAL
admet-1437	132	1	1	CARDINAL
admet-1437	132	2	2	CARDINAL
admet-1437	132	3	4	CARDINAL
admet-1437	135	1	amidon et al	FAC
admet-1437	136	1	the 1990s	DATE
admet-1437	136	2	73,74	CARDINAL
admet-1437	136	3	75-80	CARDINAL
admet-1437	137	1	5	CARDINAL
admet-1437	138	1	vl	ORG
admet-1437	139	1	bonhoeffer et al. admet	PERSON
admet-1437	139	2	2022	CARDINAL
admet-1437	139	3	253	CARDINAL
admet-1437	139	4	first	ORDINAL
admet-1437	140	1	0	CARDINAL
admet-1437	141	1	𝑠app,𝑖,𝑗	CARDINAL
admet-1437	141	2	noyes-whitney / nernst-brunner	ORG
admet-1437	142	1	∆𝑡	DATE
admet-1437	143	1	∆𝑚𝑗	ORG
admet-1437	144	1	+ ∆𝑡	DATE
admet-1437	147	1	1 µm	CARDINAL
admet-1437	148	1	1	CARDINAL
admet-1437	149	1	microsoft	ORG
admet-1437	149	2	2016	DATE
admet-1437	149	3	microsoft	ORG
admet-1437	149	4	7.1	CARDINAL
admet-1437	150	1	1	CARDINAL
admet-1437	152	1	3.72·10-4 m3	QUANTITY
admet-1437	152	2	η 1	FAC
admet-1437	152	3	30	CARDINAL
admet-1437	152	4	1364 kg/m3	QUANTITY
admet-1437	152	5	28 mg/l	QUANTITY
admet-1437	153	1	1	CARDINAL
admet-1437	154	1	1	CARDINAL
admet-1437	155	1	2	CARDINAL
admet-1437	156	1	q3	ORG
admet-1437	162	1	2022	CARDINAL
admet-1437	162	2	253	CARDINAL
admet-1437	162	3	261	CARDINAL
admet-1437	162	4	150	CARDINAL
admet-1437	163	1	8	CARDINAL
admet-1437	163	2	100	CARDINAL
admet-1437	164	1	2 to 8	CARDINAL
admet-1437	165	1	2	CARDINAL
admet-1437	165	2	q3	ORG
admet-1437	165	3	1	CARDINAL
admet-1437	165	4	2	CARDINAL
admet-1437	166	1	1 1116	CARDINAL
admet-1437	166	2	-0.4%	PERCENT
admet-1437	166	3	2443	CARDINAL
admet-1437	166	4	-1.9%	PERCENT
admet-1437	166	5	5344	DATE
admet-1437	166	6	+0.1%	PERCENT
admet-1437	166	7	0.611 2 152	MONEY
admet-1437	166	8	-3.4%	PERCENT
admet-1437	166	9	261	CARDINAL
admet-1437	166	10	+1.0%	PERCENT
admet-1437	166	11	449	CARDINAL
admet-1437	166	12	-3.6%	PERCENT
admet-1437	166	13	0.422 3 116	MONEY
admet-1437	166	14	-2.2%	PERCENT
admet-1437	166	15	201	CARDINAL
admet-1437	166	16	+0.0%	PERCENT
admet-1437	166	17	348	CARDINAL
admet-1437	166	18	-0.9%	PERCENT
admet-1437	166	19	0.427 4 78	MONEY
admet-1437	166	20	-6.0%	PERCENT
admet-1437	166	21	140	CARDINAL
admet-1437	166	22	+1.4%	PERCENT
admet-1437	166	23	252	CARDINAL
admet-1437	166	24	-3.2%	PERCENT
admet-1437	166	25	0.456 5 57 (-5.9%	PERCENT
admet-1437	166	26	111	CARDINAL
admet-1437	166	27	+2.2%	PERCENT
admet-1437	166	28	213	CARDINAL
admet-1437	166	29	0.513	CARDINAL
admet-1437	166	30	93	CARDINAL
admet-1437	166	31	162	CARDINAL
admet-1437	166	32	0.432	CARDINAL
admet-1437	166	33	90	DATE
admet-1437	166	34	150	CARDINAL
admet-1437	166	35	-7.0%	PERCENT
admet-1437	166	36	0.404	CARDINAL
admet-1437	166	37	-4.3%	PERCENT
admet-1437	166	38	79	DATE
admet-1437	166	39	+1.1%	PERCENT
admet-1437	166	40	133	CARDINAL
admet-1437	166	41	2	CARDINAL
admet-1437	168	1	2(a	CARDINAL
admet-1437	169	1	1	CARDINAL
admet-1437	169	2	about 5 μm	CARDINAL
admet-1437	169	3	2	CARDINAL
admet-1437	169	4	2(b	CARDINAL
admet-1437	172	1	81	CARDINAL
admet-1437	173	1	2(b	CARDINAL
admet-1437	173	2	second	ORDINAL
admet-1437	174	1	2(c	CARDINAL
admet-1437	175	1	2(h	CARDINAL
admet-1437	176	1	2(h	CARDINAL
admet-1437	176	2	100	CARDINAL
admet-1437	176	3	2	CARDINAL
admet-1437	178	1	about 20	CARDINAL
admet-1437	179	1	bonhoeffer et al	PERSON
admet-1437	179	2	2022	CARDINAL
admet-1437	179	3	253	CARDINAL
admet-1437	179	4	262	CARDINAL
admet-1437	179	5	2	CARDINAL
admet-1437	179	6	2	CARDINAL
admet-1437	180	1	1	CARDINAL
admet-1437	181	1	2443	CARDINAL
admet-1437	182	1	2	CARDINAL
admet-1437	183	1	261	CARDINAL
admet-1437	184	1	3	CARDINAL
admet-1437	185	1	201	CARDINAL
admet-1437	186	1	4	CARDINAL
admet-1437	187	1	140	CARDINAL
admet-1437	188	1	5	CARDINAL
admet-1437	189	1	111	CARDINAL
admet-1437	190	1	6	CARDINAL
admet-1437	191	1	93	CARDINAL
admet-1437	192	1	7	CARDINAL
admet-1437	193	1	90	CARDINAL
admet-1437	194	1	8	CARDINAL
admet-1437	195	1	79	CARDINAL
admet-1437	196	1	2022	CARDINAL
admet-1437	196	2	253	CARDINAL
admet-1437	196	3	263	CARDINAL
admet-1437	196	4	82	CARDINAL
admet-1437	200	1	3(a	CARDINAL
admet-1437	203	1	3	CARDINAL
admet-1437	207	1	3(a	CARDINAL
admet-1437	209	1	second	ORDINAL
admet-1437	209	2	third	ORDINAL
admet-1437	209	3	3(a	CARDINAL
admet-1437	210	1	bonhoeffer et al	PERSON
admet-1437	210	2	2022	CARDINAL
admet-1437	210	3	253	CARDINAL
admet-1437	210	4	264	CARDINAL
admet-1437	213	1	6	CARDINAL
admet-1437	214	1	vcell	ORG
admet-1437	215	1	𝑉cell	PERSON
admet-1437	217	1	∗	CARDINAL
admet-1437	217	2	cos𝛽	ORG
admet-1437	217	3	∗ cos𝛾	PERSON
admet-1437	217	4	7	CARDINAL
admet-1437	219	1	3	CARDINAL
admet-1437	220	1	100	CARDINAL
admet-1437	220	2	three	CARDINAL
admet-1437	221	1	between 1 and 3 µm	CARDINAL
admet-1437	221	2	more than 2 %	PERCENT
admet-1437	222	1	3	CARDINAL
admet-1437	224	1	20	CARDINAL
admet-1437	224	2	51.0	CARDINAL
admet-1437	224	3	12.2	CARDINAL
admet-1437	224	4	6.2	CARDINAL
admet-1437	224	5	12.2	CARDINAL
admet-1437	224	6	0.2 0.4 0.6 100000 0.01 0.01 0.02	QUANTITY
admet-1437	224	7	about 200	CARDINAL
admet-1437	226	1	between 6.2 to	CARDINAL
admet-1437	226	2	17.8 %	PERCENT
admet-1437	226	3	100	CARDINAL
admet-1437	227	1	20	CARDINAL
admet-1437	228	1	3(b	CARDINAL
admet-1437	233	1	2022	CARDINAL
admet-1437	233	2	253	CARDINAL
admet-1437	238	1	4	CARDINAL
admet-1437	238	2	no.1	ORG
admet-1437	238	3	6 to 8	CARDINAL
admet-1437	238	4	2443	CARDINAL
admet-1437	238	5	93	DATE
admet-1437	238	6	90	CARDINAL
admet-1437	238	7	79	CARDINAL
admet-1437	239	1	between 11° and 15° 2	QUANTITY
admet-1437	240	1	between 30° and 35° 2θ	TIME
admet-1437	241	1	11	CARDINAL
admet-1437	241	2	2θ	CARDINAL
admet-1437	241	3	4(a	CARDINAL
admet-1437	242	1	11.7°	QUANTITY
admet-1437	243	1	79	CARDINAL
admet-1437	243	2	90	CARDINAL
admet-1437	243	3	93	CARDINAL
admet-1437	244	1	2θ	CARDINAL
admet-1437	245	1	30° to 35°	TIME
admet-1437	248	1	100 %	PERCENT
admet-1437	250	1	nist® srm	ORG
admet-1437	250	2	675	CARDINAL
admet-1437	251	1	4	CARDINAL
admet-1437	253	1	6 to 8	CARDINAL
admet-1437	253	2	approximately 31	CARDINAL
admet-1437	254	1	bonhoeffer et al	PERSON
admet-1437	254	2	2022	CARDINAL
admet-1437	254	3	253	CARDINAL
admet-1437	254	4	287 266	CARDINAL
admet-1437	254	5	4	CARDINAL
admet-1437	254	6	nanocrystal particle	ORG
admet-1437	255	1	no.1	ORG
admet-1437	255	2	6 to 8	CARDINAL
admet-1437	255	3	13.7	CARDINAL
admet-1437	255	4	2θ	CARDINAL
admet-1437	256	1	618 320	CARDINAL
admet-1437	256	2	516 325	CARDINAL
admet-1437	256	3	13.7°	CARDINAL
admet-1437	257	1	approximately 21	CARDINAL
admet-1437	258	1	21	CARDINAL
admet-1437	258	2	about 7000	CARDINAL
admet-1437	259	1	about 28 %	PERCENT
admet-1437	259	2	2000	DATE
admet-1437	259	3	three	CARDINAL
admet-1437	259	4	68 %	PERCENT
admet-1437	260	1	21	CARDINAL
admet-1437	263	1	79	CARDINAL
admet-1437	263	2	8	CARDINAL
admet-1437	263	3	2	CARDINAL
admet-1437	263	4	2(h	CARDINAL
admet-1437	264	1	30	CARDINAL
admet-1437	264	2	20	CARDINAL
admet-1437	264	3	2(h	CARDINAL
admet-1437	267	1	50 °	QUANTITY
admet-1437	267	2	a week	DATE
admet-1437	269	1	100 %	PERCENT
admet-1437	269	2	0 %	PERCENT
admet-1437	271	1	4 %	PERCENT
admet-1437	271	2	13.79 %	PERCENT
admet-1437	273	1	three	CARDINAL
admet-1437	274	1	10.0 ± 0.050 mg	QUANTITY
admet-1437	276	1	9	CARDINAL
admet-1437	276	2	5	CARDINAL
admet-1437	278	1	17°	TIME
admet-1437	280	1	three	CARDINAL
admet-1437	280	2	four	CARDINAL
admet-1437	280	3	6	CARDINAL
admet-1437	281	1	95 %	PERCENT
admet-1437	281	2	microsoft	ORG
admet-1437	281	3	2016	DATE
admet-1437	282	1	2022	CARDINAL
admet-1437	282	2	253	CARDINAL
admet-1437	282	3	267	CARDINAL
admet-1437	283	1	5	CARDINAL
admet-1437	283	2	between 10.5° to 17.5° 2θ	QUANTITY
admet-1437	283	3	100 %	PERCENT
admet-1437	283	4	100 %	PERCENT
admet-1437	283	5	no.1	ORG
admet-1437	283	6	5	CARDINAL
admet-1437	283	7	8	CARDINAL
admet-1437	283	8	2443	CARDINAL
admet-1437	283	9	111	CARDINAL
admet-1437	283	10	79	CARDINAL
admet-1437	284	1	6	CARDINAL
admet-1437	285	1	16.9994° 2θ	QUANTITY
admet-1437	285	2	95 %	PERCENT
admet-1437	285	3	no.1	ORG
admet-1437	285	4	5	CARDINAL
admet-1437	285	5	8	CARDINAL
admet-1437	285	6	2443	CARDINAL
admet-1437	285	7	111	CARDINAL
admet-1437	285	8	79	CARDINAL
admet-1437	286	1	1	CARDINAL
admet-1437	286	2	5	DATE
admet-1437	286	3	8	DATE
admet-1437	286	4	5	CARDINAL
admet-1437	288	1	1	CARDINAL
admet-1437	288	2	− 𝑤cryst	PERSON
admet-1437	288	3	one	CARDINAL
admet-1437	288	4	5	CARDINAL
admet-1437	289	1	8 %	PERCENT
admet-1437	289	2	21.5 %	PERCENT
admet-1437	290	1	5	CARDINAL
admet-1437	291	1	bonhoeffer et al. admet	PERSON
admet-1437	291	2	2022	CARDINAL
admet-1437	291	3	253	CARDINAL
admet-1437	291	4	5	CARDINAL
admet-1437	291	5	no.1	ORG
admet-1437	291	6	5	CARDINAL
admet-1437	291	7	8	DATE
admet-1437	293	1	0.3 5	CARDINAL
admet-1437	293	2	111	CARDINAL
admet-1437	293	3	23	CARDINAL
admet-1437	293	4	80	CARDINAL
admet-1437	293	5	20 7.8	TIME
admet-1437	293	6	2	CARDINAL
admet-1437	298	1	no more than 1 %	PERCENT
admet-1437	298	2	20 to 30	CARDINAL
admet-1437	298	3	8	CARDINAL
admet-1437	298	4	6	CARDINAL
admet-1437	298	5	5	CARDINAL
admet-1437	298	6	8	CARDINAL
admet-1437	300	1	5	CARDINAL
admet-1437	300	2	6.3	CARDINAL
admet-1437	300	3	12.3	CARDINAL
admet-1437	300	4	17.9	CARDINAL
admet-1437	300	5	17.4 25.1	CARDINAL
admet-1437	300	6	xrpd	NORP
admet-1437	300	7	2	CARDINAL
admet-1437	300	8	5	CARDINAL
admet-1437	300	9	8	CARDINAL
admet-1437	300	10	5	CARDINAL
admet-1437	300	11	6	CARDINAL
admet-1437	301	1	at least 1	CARDINAL
admet-1437	301	2	2	CARDINAL
admet-1437	302	1	z=3	ORG
admet-1437	303	1	three	CARDINAL
admet-1437	303	2	about 3.3	CARDINAL
admet-1437	304	1	xrpd	NORP
admet-1437	304	2	27	CARDINAL
admet-1437	304	3	1	CARDINAL
admet-1437	304	4	5	CARDINAL
admet-1437	309	1	81	CARDINAL
admet-1437	311	1	about 32	CARDINAL
admet-1437	311	2	35	CARDINAL
admet-1437	312	1	2022	CARDINAL
admet-1437	312	2	253	CARDINAL
admet-1437	312	3	269	CARDINAL
admet-1437	313	1	sapp	ORG
admet-1437	313	2	2	CARDINAL
admet-1437	313	3	3	CARDINAL
admet-1437	314	1	2.7	CARDINAL
admet-1437	314	2	179	CARDINAL
admet-1437	315	1	111	CARDINAL
admet-1437	315	2	3	CARDINAL
admet-1437	316	1	7	CARDINAL
admet-1437	317	1	4 %	PERCENT
admet-1437	319	1	2	CARDINAL
admet-1437	320	1	2	CARDINAL
admet-1437	320	2	8,43	CARDINAL
admet-1437	328	1	9 to 15	CARDINAL
admet-1437	328	2	7	CARDINAL
admet-1437	329	1	18	CARDINAL
admet-1437	331	1	1 µm	CARDINAL
admet-1437	333	1	two	CARDINAL
admet-1437	333	2	3 and 20	CARDINAL
admet-1437	333	3	roughly 1/3	CARDINAL
admet-1437	333	4	1/20	CARDINAL
admet-1437	334	1	first	ORDINAL
admet-1437	334	2	x5,3	PERSON
admet-1437	335	1	20	CARDINAL
admet-1437	335	2	3	CARDINAL
admet-1437	335	3	31,54	CARDINAL
admet-1437	337	1	bonhoeffer et al	PERSON
admet-1437	337	2	2022	CARDINAL
admet-1437	337	3	253	CARDINAL
admet-1437	337	4	7	CARDINAL
admet-1437	337	5	2	CARDINAL
admet-1437	337	6	3	CARDINAL
admet-1437	337	7	22 °	QUANTITY
admet-1437	339	1	3	CARDINAL
admet-1437	339	2	261	CARDINAL
admet-1437	339	3	0.25	CARDINAL
admet-1437	339	4	201	CARDINAL
admet-1437	339	5	39.8	CARDINAL
admet-1437	339	6	0.25	CARDINAL
admet-1437	339	7	8.9 140	CARDINAL
admet-1437	339	8	0.25	CARDINAL
admet-1437	339	9	111	CARDINAL
admet-1437	339	10	49.9	CARDINAL
admet-1437	339	11	0.25	CARDINAL
admet-1437	339	12	0.25	CARDINAL
admet-1437	339	13	0.25	CARDINAL
admet-1437	339	14	55.7 9	TIME
admet-1437	339	15	0.075 2.7	CARDINAL
admet-1437	339	16	41.6	CARDINAL
admet-1437	339	17	0.125 4.5	CARDINAL
admet-1437	339	18	47.2	CARDINAL
admet-1437	339	19	0.25	CARDINAL
admet-1437	339	20	49.9	CARDINAL
admet-1437	339	21	0.5 18	CARDINAL
admet-1437	339	22	111	CARDINAL
admet-1437	339	23	51.3	CARDINAL
admet-1437	339	24	111	CARDINAL
admet-1437	339	25	51.9	CARDINAL
admet-1437	339	26	14	CARDINAL
admet-1437	339	27	2.5 89	CARDINAL
admet-1437	339	28	52.1	CARDINAL
admet-1437	339	29	15	CARDINAL
admet-1437	339	30	179	CARDINAL
admet-1437	339	31	111	CARDINAL
admet-1437	339	32	52.5	CARDINAL
admet-1437	340	1	65.5 ±	MONEY
admet-1437	340	2	49.5 ± 1.1 mj	MONEY
admet-1437	340	3	16.0 ± 4.5	MONEY
admet-1437	341	1	55	CARDINAL
admet-1437	342	1	65	CARDINAL
admet-1437	343	1	65	CARDINAL
admet-1437	344	1	1 to 8	CARDINAL
admet-1437	344	2	7	CARDINAL
admet-1437	344	3	4	CARDINAL
admet-1437	346	1	7(b	CARDINAL
admet-1437	346	2	1 to 8	CARDINAL
admet-1437	346	3	7	CARDINAL
admet-1437	349	1	30	CARDINAL
admet-1437	350	1	2022	CARDINAL
admet-1437	350	2	253	CARDINAL
admet-1437	350	3	271	CARDINAL
admet-1437	351	1	83	CARDINAL
admet-1437	352	1	7	CARDINAL
admet-1437	352	2	7	CARDINAL
admet-1437	352	3	3	CARDINAL
admet-1437	353	1	4	CARDINAL
admet-1437	354	1	2	CARDINAL
admet-1437	355	1	7	CARDINAL
admet-1437	355	2	3	CARDINAL
admet-1437	355	3	0.01	CARDINAL
admet-1437	355	4	2	CARDINAL
admet-1437	355	5	4.5	QUANTITY
admet-1437	356	1	8	CARDINAL
admet-1437	356	2	three	CARDINAL
admet-1437	356	3	30	CARDINAL
admet-1437	357	1	about two	CARDINAL
admet-1437	358	1	4	CARDINAL
admet-1437	359	1	8	CARDINAL
admet-1437	359	2	three	CARDINAL
admet-1437	360	1	the noyes-whitney/nernst-brunner	ORG
admet-1437	361	1	7	DATE
admet-1437	361	2	bonhoeffer et al. admet	PERSON
admet-1437	361	3	2022	CARDINAL
admet-1437	361	4	253	CARDINAL
admet-1437	361	5	3	CARDINAL
admet-1437	363	1	8	CARDINAL
admet-1437	363	2	2	CARDINAL
admet-1437	363	3	30	CARDINAL
admet-1437	364	1	111	CARDINAL
admet-1437	364	2	9 to	CARDINAL
admet-1437	364	3	14	CARDINAL
admet-1437	364	4	7	CARDINAL
admet-1437	364	5	9	CARDINAL
admet-1437	364	6	0.51	CARDINAL
admet-1437	366	1	30	CARDINAL
admet-1437	366	2	1 to 8	CARDINAL
admet-1437	368	1	1	CARDINAL
admet-1437	368	2	2	CARDINAL
admet-1437	369	1	two	CARDINAL
admet-1437	370	1	0.51	CARDINAL
admet-1437	370	2	0.4	CARDINAL
admet-1437	370	3	0.3	CARDINAL
admet-1437	370	4	0.2	CARDINAL
admet-1437	370	5	0.1	CARDINAL
admet-1437	370	6	0.0001	CARDINAL
admet-1437	371	1	9	CARDINAL
admet-1437	374	1	0.3	CARDINAL
admet-1437	375	1	0.0001	CARDINAL
admet-1437	375	2	first	ORDINAL
admet-1437	377	1	2022	CARDINAL
admet-1437	377	2	253	CARDINAL
admet-1437	377	3	273	CARDINAL
admet-1437	381	1	2	CARDINAL
admet-1437	381	2	x10,3	NORP
admet-1437	386	1	9	CARDINAL
admet-1437	387	1	111	CARDINAL
admet-1437	388	1	111	CARDINAL
admet-1437	388	2	0.51	CARDINAL
admet-1437	388	3	0.4	CARDINAL
admet-1437	388	4	0.3	CARDINAL
admet-1437	388	5	0.2	CARDINAL
admet-1437	388	6	0.1	CARDINAL
admet-1437	388	7	0.0001	CARDINAL
admet-1437	388	8	30	CARDINAL
admet-1437	389	1	2	CARDINAL
admet-1437	390	1	10 %	PERCENT
admet-1437	390	2	18	CARDINAL
admet-1437	391	1	18	CARDINAL
admet-1437	392	1	1	CARDINAL
admet-1437	393	1	22 °	QUANTITY
admet-1437	393	2	several weeks	DATE
admet-1437	393	3	less than 10 %	PERCENT
admet-1437	394	1	bonhoeffer et al	PERSON
admet-1437	394	2	2022	CARDINAL
admet-1437	394	3	253	CARDINAL
admet-1437	395	1	84-86	CARDINAL
admet-1437	398	1	20 ml	QUANTITY
admet-1437	398	2	250 ml	QUANTITY
admet-1437	399	1	84-86	CARDINAL
admet-1437	400	1	3 and 4.5	CARDINAL
admet-1437	400	2	250 ml	QUANTITY
admet-1437	400	3	900 ml	QUANTITY
admet-1437	401	1	84-86	CARDINAL
admet-1437	403	1	25	CARDINAL
admet-1437	404	1	1	CARDINAL
admet-1437	404	2	2	DATE
admet-1437	404	3	5	DATE
admet-1437	404	4	8	CARDINAL
admet-1437	404	5	2	CARDINAL
admet-1437	404	6	10	CARDINAL
admet-1437	405	1	10(a	CARDINAL
admet-1437	405	2	10(b	CARDINAL
admet-1437	406	1	fed	ORG
admet-1437	406	2	11(a	DATE
admet-1437	406	3	11(b	CARDINAL
admet-1437	408	1	8)	CARDINAL
admet-1437	408	2	10(a	CARDINAL
admet-1437	408	3	11(a	DATE
admet-1437	410	1	about 2	CARDINAL
admet-1437	411	1	25 mg	QUANTITY
admet-1437	411	2	250 ml	QUANTITY
admet-1437	411	3	2	CARDINAL
admet-1437	411	4	10(a	CARDINAL
admet-1437	411	5	25 mg	QUANTITY
admet-1437	411	6	10(a	CARDINAL
admet-1437	412	1	10(b	CARDINAL
admet-1437	412	2	11(b	CARDINAL
admet-1437	412	3	9	CARDINAL
admet-1437	416	1	2022	CARDINAL
admet-1437	416	2	253	CARDINAL
admet-1437	416	3	275	CARDINAL
admet-1437	416	4	10	CARDINAL
admet-1437	416	5	2443	CARDINAL
admet-1437	416	6	261	CARDINAL
admet-1437	416	7	111	CARDINAL
admet-1437	416	8	79	CARDINAL
admet-1437	416	9	2	CARDINAL
admet-1437	416	10	25 mg	QUANTITY
admet-1437	416	11	100 mg	QUANTITY
admet-1437	416	12	20 ml and	QUANTITY
admet-1437	416	13	250 ml	QUANTITY
admet-1437	416	14	2	CARDINAL
admet-1437	419	1	11	CARDINAL
admet-1437	420	1	fed	ORG
admet-1437	420	2	2443	CARDINAL
admet-1437	420	3	261	CARDINAL
admet-1437	420	4	111	CARDINAL
admet-1437	420	5	79	CARDINAL
admet-1437	420	6	2	CARDINAL
admet-1437	420	7	25 mg	QUANTITY
admet-1437	420	8	100 mg	QUANTITY
admet-1437	420	9	250 ml	QUANTITY
admet-1437	423	1	1	CARDINAL
admet-1437	424	1	bonhoeffer et al. admet	PERSON
admet-1437	424	2	2022	CARDINAL
admet-1437	424	3	253	CARDINAL
admet-1437	424	4	276	CARDINAL
admet-1437	424	5	87-89	CARDINAL
admet-1437	426	1	20 to 100	CARDINAL
admet-1437	427	1	90	CARDINAL
admet-1437	428	1	90	CARDINAL
admet-1437	430	1	2	CARDINAL
admet-1437	430	2	3	DATE
admet-1437	430	3	4.5	CARDINAL
admet-1437	431	1	25	CARDINAL
admet-1437	431	2	1	CARDINAL
admet-1437	431	3	2	DATE
admet-1437	431	4	5	DATE
admet-1437	431	5	8	CARDINAL
admet-1437	431	6	2	CARDINAL
admet-1437	432	1	12	CARDINAL
admet-1437	433	1	1	CARDINAL
admet-1437	433	2	2	CARDINAL
admet-1437	433	3	25	DATE
admet-1437	433	4	100 %	PERCENT
admet-1437	434	1	1	CARDINAL
admet-1437	435	1	1	CARDINAL
admet-1437	436	1	12	CARDINAL
admet-1437	437	1	2443	CARDINAL
admet-1437	437	2	261	CARDINAL
admet-1437	437	3	111	CARDINAL
admet-1437	437	4	79	CARDINAL
admet-1437	437	5	2	CARDINAL
admet-1437	437	6	25 mg	QUANTITY
admet-1437	437	7	100 mg	QUANTITY
admet-1437	437	8	900 ml	QUANTITY
admet-1437	437	9	2	CARDINAL
admet-1437	439	1	13(a	CARDINAL
admet-1437	439	2	1 to 5	CARDINAL
admet-1437	439	3	8	CARDINAL
admet-1437	439	4	2	CARDINAL
admet-1437	439	5	100 mg	QUANTITY
admet-1437	439	6	3	CARDINAL
admet-1437	439	7	4	CARDINAL
admet-1437	440	1	2443	CARDINAL
admet-1437	441	1	258	CARDINAL
admet-1437	442	1	only a few seconds	TIME
admet-1437	446	1	2022	CARDINAL
admet-1437	446	2	253	CARDINAL
admet-1437	446	3	277	CARDINAL
admet-1437	447	1	13	CARDINAL
admet-1437	448	1	2443	CARDINAL
admet-1437	448	2	261	CARDINAL
admet-1437	448	3	201	CARDINAL
admet-1437	448	4	140	CARDINAL
admet-1437	448	5	111	CARDINAL
admet-1437	448	6	79	CARDINAL
admet-1437	448	7	2	CARDINAL
admet-1437	448	8	100	CARDINAL
admet-1437	448	9	4	CARDINAL
admet-1437	451	1	14(a	CARDINAL
admet-1437	451	2	2443	CARDINAL
admet-1437	451	3	201	CARDINAL
admet-1437	451	4	79	CARDINAL
admet-1437	451	5	1	CARDINAL
admet-1437	451	6	3	CARDINAL
admet-1437	451	7	8	CARDINAL
admet-1437	451	8	2	CARDINAL
admet-1437	452	1	14(c	CARDINAL
admet-1437	458	1	15	CARDINAL
admet-1437	459	1	111	CARDINAL
admet-1437	459	2	1 to 100	CARDINAL
admet-1437	462	1	16(a	CARDINAL
admet-1437	462	2	1	CARDINAL
admet-1437	462	3	4	DATE
admet-1437	462	4	40	DATE
admet-1437	462	5	111	CARDINAL
admet-1437	463	1	1	CARDINAL
admet-1437	463	2	16(a	CARDINAL
admet-1437	465	1	4	CARDINAL
admet-1437	465	2	40	CARDINAL
admet-1437	467	1	bonhoeffer et al	PERSON
admet-1437	467	2	2022	CARDINAL
admet-1437	467	3	253	CARDINAL
admet-1437	467	4	14	CARDINAL
admet-1437	468	1	100 mg	QUANTITY
admet-1437	468	2	4	CARDINAL
admet-1437	468	3	12	CARDINAL
admet-1437	470	1	2443	CARDINAL
admet-1437	472	1	201	CARDINAL
admet-1437	474	1	79	CARDINAL
admet-1437	475	1	15	CARDINAL
admet-1437	477	1	111	CARDINAL
admet-1437	477	2	2	CARDINAL
admet-1437	477	3	3	CARDINAL
admet-1437	477	4	1	CARDINAL
admet-1437	477	5	2	DATE
admet-1437	477	6	4	DATE
admet-1437	477	7	10	DATE
admet-1437	477	8	40	DATE
admet-1437	477	9	100	CARDINAL
admet-1437	478	1	admet & dmpk 10(4	ORG
admet-1437	478	2	2022	CARDINAL
admet-1437	478	3	253	CARDINAL
admet-1437	478	4	279	CARDINAL
admet-1437	478	5	16	CARDINAL
admet-1437	480	1	111	CARDINAL
admet-1437	480	2	3	CARDINAL
admet-1437	480	3	12	CARDINAL
admet-1437	481	1	1	CARDINAL
admet-1437	482	1	4	CARDINAL
admet-1437	483	1	40	CARDINAL
admet-1437	485	1	47 / 79	MONEY
admet-1437	486	1	about 20	CARDINAL
admet-1437	487	1	200	CARDINAL
admet-1437	487	2	about 20 %	PERCENT
admet-1437	489	1	3 and ph 4.5	QUANTITY
admet-1437	490	1	2	CARDINAL
admet-1437	492	1	bonhoeffer et al. admet	PERSON
admet-1437	492	2	2022	CARDINAL
admet-1437	492	3	253	CARDINAL
admet-1437	496	1	the noyes-whitney / nernst-brunner	ORG
admet-1437	496	2	30	CARDINAL
admet-1437	496	3	18	CARDINAL
admet-1437	496	4	10 %	PERCENT
admet-1437	501	1	only a few seconds	TIME
admet-1437	502	1	1	CARDINAL
admet-1437	506	1	armin katzenstein	PERSON
admet-1437	506	2	dirk maertin	PERSON
admet-1437	506	3	eugen fink	PERSON
admet-1437	506	4	jasmin muminović	PERSON
admet-1437	506	5	mandy broda	PERSON
admet-1437	506	6	saša jović	ORG
admet-1437	506	7	novartis pharma ag	ORG
admet-1437	506	8	dr.	PERSON
admet-1437	506	9	isabelle	PERSON
admet-1437	506	10	karin rapp	ORG
admet-1437	506	11	novartis pharma ag	ORG
admet-1437	508	1	2022	CARDINAL
admet-1437	508	2	253	CARDINAL
admet-1437	508	3	281	CARDINAL
admet-1437	508	4	kb boltzmann	PERSON
admet-1437	508	5	mass nist national institute of standards	ORG
admet-1437	508	6	one	CARDINAL
admet-1437	508	7	vl	ORG
admet-1437	508	8	1	CARDINAL
admet-1437	508	9	b.r.	GPE
admet-1437	509	1	nanosuspensions	PERSON
admet-1437	510	1	3	CARDINAL
admet-1437	510	2	785	CARDINAL
admet-1437	512	1	2	CARDINAL
admet-1437	512	2	e.m. liversidge	GPE
admet-1437	512	3	g.g. liversidge	GPE
admet-1437	512	4	e.r. cooper	PERSON
admet-1437	513	1	nanosizing	PERSON
admet-1437	514	1	european journal of pharmaceutical sciences	ORG
admet-1437	514	2	18 (2003	DATE
admet-1437	514	3	113	CARDINAL
admet-1437	515	1	https://doi.org/10.1016/s0928-0987(02)00251-8	ORG
admet-1437	516	1	3	CARDINAL
admet-1437	516	2	f. kesisoglou	PERSON
admet-1437	516	3	s. panmai	PERSON
admet-1437	516	4	y. wu	PERSON
admet-1437	517	1	nanosizing	PERSON
admet-1437	518	1	59	CARDINAL
admet-1437	518	2	2007	DATE
admet-1437	518	3	631-644	CARDINAL
admet-1437	520	1	4	CARDINAL
admet-1437	520	2	j. wong	PERSON
admet-1437	520	3	a. brugger	PERSON
admet-1437	520	4	a. khare	PERSON
admet-1437	520	5	m. chaubal	PERSON
admet-1437	520	6	p. papadopoulos	PERSON
admet-1437	520	7	b. rabinow	PERSON
admet-1437	520	8	j. kipp	PERSON
admet-1437	520	9	j. ning	PERSON
admet-1437	521	1	60	CARDINAL
admet-1437	521	2	939	CARDINAL
admet-1437	523	1	5	CARDINAL
admet-1437	523	2	e.m. liversidge	GPE
admet-1437	523	3	g.g.	GPE
admet-1437	525	1	63	CARDINAL
admet-1437	525	2	2011	DATE
admet-1437	525	3	427	CARDINAL
admet-1437	527	1	https://doi.org/10.1016/s0928-0987(02)00251-8	ORG
admet-1437	527	2	bonhoeffer et al. admet	PERSON
admet-1437	527	3	2022	CARDINAL
admet-1437	527	4	253	CARDINAL
admet-1437	527	5	6	CARDINAL
admet-1437	527	6	müller	PERSON
admet-1437	527	7	s. gohla	PERSON
admet-1437	527	8	c.m. keck	PERSON
admet-1437	529	1	european journal of pharmaceutics	ORG
admet-1437	529	2	biopharmaceutics 78 (	ORG
admet-1437	529	3	2011	DATE
admet-1437	529	4	1	CARDINAL
admet-1437	531	1	7	CARDINAL
admet-1437	531	2	müller	PERSON
admet-1437	531	3	c.m. keck	PERSON
admet-1437	532	1	twenty years	DATE
admet-1437	533	1	european journal of pharmaceutics	ORG
admet-1437	533	2	biopharmaceutics	ORG
admet-1437	533	3	80	CARDINAL
admet-1437	533	4	2012	DATE
admet-1437	533	5	1	CARDINAL
admet-1437	534	1	8	CARDINAL
admet-1437	534	2	shah	PERSON
admet-1437	534	3	s.b.	GPE
admet-1437	534	4	r.h. dave.	PERSON
admet-1437	536	1	105	CARDINAL
admet-1437	536	2	2016	CARDINAL
admet-1437	536	3	10	CARDINAL
admet-1437	538	1	9	CARDINAL
admet-1437	538	2	chen	PERSON
admet-1437	538	3	m. john	PERSON
admet-1437	538	4	s.l. lee	PERSON
admet-1437	538	5	tyner	PERSON
admet-1437	540	1	19	CARDINAL
admet-1437	540	2	2017	CARDINAL
admet-1437	540	3	642	CARDINAL
admet-1437	542	1	10	CARDINAL
admet-1437	542	2	c.j. strachan	PERSON
admet-1437	544	1	international journal of pharmaceutics	ORG
admet-1437	544	2	586	CARDINAL
admet-1437	544	3	2020) 119492	DATE
admet-1437	546	1	11	CARDINAL
admet-1437	546	2	d. dahlgren	PERSON
admet-1437	546	3	e. sjögren	PERSON
admet-1437	546	4	h. lennernäs	PERSON
admet-1437	548	1	8	CARDINAL
admet-1437	548	2	2020	DATE
admet-1437	548	3	375	CARDINAL
admet-1437	549	1	12	CARDINAL
admet-1437	549	2	z. ma	PERSON
admet-1437	549	3	h. zhang	PERSON
admet-1437	549	4	y. wang	PERSON
admet-1437	549	5	x. tang	PERSON
admet-1437	551	1	16	CARDINAL
admet-1437	551	2	2019	CARDINAL
admet-1437	551	3	347	CARDINAL
admet-1437	553	1	13	CARDINAL
admet-1437	553	2	r. jain	PERSON
admet-1437	553	3	j. meyer	PERSON
admet-1437	553	4	a. wehr	PERSON
admet-1437	553	5	b. rege	PERSON
admet-1437	553	6	l. von moltke	PERSON
admet-1437	553	7	p.j	GPE
admet-1437	553	8	weiden	GPE
admet-1437	555	1	25	CARDINAL
admet-1437	555	2	2020	DATE
admet-1437	555	3	323	CARDINAL
admet-1437	556	1	https://doi.org/10.1017/s1092852919000816	ORG
admet-1437	557	1	14	CARDINAL
admet-1437	557	2	j. bae	PERSON
admet-1437	557	3	y. zhang	PERSON
admet-1437	557	4	b. qin	PERSON
admet-1437	557	5	y. wang	PERSON
admet-1437	557	6	d. kozak	PERSON
admet-1437	557	7	m. ashraf	PERSON
admet-1437	557	8	x. xu	PERSON
admet-1437	558	1	international journal of pharmaceutics 604 (	ORG
admet-1437	558	2	2021	CARDINAL
admet-1437	558	3	120767	DATE
admet-1437	560	1	15	CARDINAL
admet-1437	560	2	e. merisko-liversidge	PERSON
admet-1437	560	3	g.g.	GPE
admet-1437	562	1	63	CARDINAL
admet-1437	562	2	2011	DATE
admet-1437	562	3	427	CARDINAL
admet-1437	564	1	16	CARDINAL
admet-1437	566	1	international journal of pharmaceutics	ORG
admet-1437	566	2	453	CARDINAL
admet-1437	566	3	2013	DATE
admet-1437	566	4	142	CARDINAL
admet-1437	568	1	17	CARDINAL
admet-1437	568	2	m. li	PERSON
admet-1437	568	3	m. azad	PERSON
admet-1437	568	4	r. dave	PERSON
admet-1437	568	5	e. bilgili	PERSON
admet-1437	570	1	8 (	PERCENT
admet-1437	570	2	2016	CARDINAL
admet-1437	570	3	17	DATE
admet-1437	571	1	18	CARDINAL
admet-1437	571	2	m. malamatari	PERSON
admet-1437	572	1	taylor	PERSON
admet-1437	572	2	s. malamataris	PERSON
admet-1437	572	3	d. douroumis	PERSON
admet-1437	572	4	k. kachrimanis	PERSON
admet-1437	574	1	today	DATE
admet-1437	574	2	23	CARDINAL
admet-1437	574	3	2018	DATE
admet-1437	574	4	534	CARDINAL
admet-1437	576	1	19	CARDINAL
admet-1437	576	2	j. hirvonen	PERSON
admet-1437	578	1	international journal of pharmaceutics 537 (	ORG
admet-1437	578	2	2018	DATE
admet-1437	578	3	73	CARDINAL
admet-1437	580	1	20	CARDINAL
admet-1437	580	2	m. inkyo	PERSON
admet-1437	580	3	r. yumoto	PERSON
admet-1437	580	4	j. nagai	PERSON
admet-1437	580	5	m. takano	PERSON
admet-1437	580	6	s. nagata	PERSON
admet-1437	582	1	38	CARDINAL
admet-1437	582	2	2012	DATE
admet-1437	584	1	21	CARDINAL
admet-1437	584	2	m. li	PERSON
admet-1437	584	3	n. yaragudi	PERSON
admet-1437	584	4	a. afolabi	PERSON
admet-1437	584	5	r. dave	PERSON
admet-1437	584	6	e. bilgili	PERSON
admet-1437	585	1	sub-100 nm drug particle	ORG
admet-1437	586	1	130	CARDINAL
admet-1437	586	2	2015	CARDINAL
admet-1437	586	3	207.220	CARDINAL
admet-1437	588	1	22	CARDINAL
admet-1437	588	2	d. juenemann	PERSON
admet-1437	588	3	e. jantratid	PERSON
admet-1437	588	4	c. wagner	PERSON
admet-1437	588	5	c. reppas	PERSON
admet-1437	588	6	m. vertzoni	PERSON
admet-1437	588	7	j.b.	PERSON
admet-1437	588	8	dressman	PERSON
admet-1437	589	1	https://doi.org/10.1016/j.ejpb.2011.09.012	ORG
admet-1437	589	2	http://dx.doi.org/-10.1002/jps.24694 http://dx.doi.org/-10.1002/jps.24694	PRODUCT
admet-1437	591	1	https://doi.org/10.1017/s1092852919000816	FAC
admet-1437	591	2	2022	CARDINAL
admet-1437	591	3	253	CARDINAL
admet-1437	591	4	283	CARDINAL
admet-1437	592	1	european journal of pharmaceutics	ORG
admet-1437	592	2	biopharmaceutics 77 (	ORG
admet-1437	592	3	2011	DATE
admet-1437	592	4	257264	DATE
admet-1437	594	1	23	CARDINAL
admet-1437	594	2	j. brouwers	PERSON
admet-1437	594	3	m. corsetti	PERSON
admet-1437	594	4	p. augustijns	PERSON
admet-1437	596	1	european journal of pharmaceutical sciences	ORG
admet-1437	596	2	77	CARDINAL
admet-1437	596	3	2015	CARDINAL
admet-1437	596	4	40	CARDINAL
admet-1437	598	1	24	CARDINAL
admet-1437	598	2	d. dahlgren	GPE
admet-1437	598	3	s. berg	PERSON
admet-1437	598	4	j. westergren	PERSON
admet-1437	598	5	b. abrahamsson	PERSON
admet-1437	598	6	c. tannergren	PERSON
admet-1437	598	7	e. sjögren	PERSON
admet-1437	598	8	h. lennernäs	PERSON
admet-1437	599	1	aprepitant nanoformulations	PERSON
admet-1437	600	1	14	DATE
admet-1437	600	2	2017	CARDINAL
admet-1437	600	3	4233-4242	DATE
admet-1437	601	1	https://doi.org/10.1021/-acs.molpharmaceut.7b00294	ORDINAL
admet-1437	602	1	25	CARDINAL
admet-1437	602	2	j. westergren	PERSON
admet-1437	602	3	d. dahlgren	GPE
admet-1437	602	4	h. lennernäs	PERSON
admet-1437	602	5	e. sjögren	PERSON
admet-1437	604	1	european journal of pharmaceutics	ORG
admet-1437	604	2	biopharmaceutics	ORG
admet-1437	604	3	133	CARDINAL
admet-1437	604	4	2018	DATE
admet-1437	604	5	70-76	DATE
admet-1437	606	1	26	CARDINAL
admet-1437	606	2	n. patel	PERSON
admet-1437	606	3	d.b. turner	PERSON
admet-1437	606	4	e. kostewicza	PERSON
admet-1437	606	5	m. kuentz	PERSON
admet-1437	606	6	k.j.	GPE
admet-1437	606	7	j. dressman	PERSON
admet-1437	607	1	fed	ORG
admet-1437	608	1	european journal of pharmaceutical sciences	ORG
admet-1437	608	2	138	CARDINAL
admet-1437	608	3	2019) 105031	DATE
admet-1437	610	1	27	CARDINAL
admet-1437	610	2	m. imono	PERSON
admet-1437	610	3	h. uchiyama	PERSON
admet-1437	610	4	s. yoshida	PERSON
admet-1437	610	5	s. miyazaki	PERSON
admet-1437	610	6	n. tamura	PERSON
admet-1437	610	7	h. tsutsumimoto	PERSON
admet-1437	610	8	k. kadota	PERSON
admet-1437	612	1	european journal of pharmaceutics	ORG
admet-1437	612	2	biopharmaceutics	ORG
admet-1437	612	3	146	CARDINAL
admet-1437	612	4	2020	DATE
admet-1437	612	5	84	CARDINAL
admet-1437	614	1	28	CARDINAL
admet-1437	614	2	m. guo	PERSON
admet-1437	614	3	m. wei	PERSON
admet-1437	614	4	w. li	PERSON
admet-1437	614	5	m. guo	PERSON
admet-1437	614	6	c. guo.	PERSON
admet-1437	614	7	m. ma	PERSON
admet-1437	614	8	y. wang	PERSON
admet-1437	614	9	z. yang	PERSON
admet-1437	614	10	m. li	PERSON
admet-1437	614	11	q. fu	PERSON
admet-1437	614	12	l. yang	PERSON
admet-1437	614	13	z.	PERSON
admet-1437	616	1	307	CARDINAL
admet-1437	616	2	2019	CARDINAL
admet-1437	616	3	64	CARDINAL
admet-1437	618	1	29	CARDINAL
admet-1437	618	2	b. abrahamsson	PERSON
admet-1437	618	3	m. mcallister	PERSON
admet-1437	618	4	p. augustijns	PERSON
admet-1437	618	5	p. zane	PERSON
admet-1437	618	6	j. butler	PERSON
admet-1437	618	7	r. holm	PERSON
admet-1437	618	8	a. lindahl	PERSON
admet-1437	618	9	a. müllertz	PERSON
admet-1437	618	10	x. pepin	PERSON
admet-1437	618	11	a. rostami-hodjegan	PERSON
admet-1437	618	12	e. sjögren	PERSON
admet-1437	618	13	m. berntsson	PERSON
admet-1437	618	14	h. lennernäs	PERSON
admet-1437	619	1	six years	DATE
admet-1437	620	1	european journal of pharmaceutics	ORG
admet-1437	620	2	biopharmaceutics	ORG
admet-1437	620	3	152	CARDINAL
admet-1437	620	4	2020	DATE
admet-1437	620	5	236	CARDINAL
admet-1437	622	1	30	CARDINAL
admet-1437	622	2	j.b. eriksen	PERSON
admet-1437	622	3	a. bauer-brandl	PERSON
admet-1437	622	4	j. rantanen	PERSON
admet-1437	622	5	k. löbmann	PERSON
admet-1437	624	1	international journal of pharmaceutics	ORG
admet-1437	624	2	3 (	CARDINAL
admet-1437	624	3	2021	CARDINAL
admet-1437	624	4	100083	DATE
admet-1437	626	1	31	CARDINAL
admet-1437	626	2	p. liu	PERSON
admet-1437	626	3	o. de wulf	PERSON
admet-1437	626	4	j. laru	PERSON
admet-1437	626	5	t. heikkilä	PERSON
admet-1437	626	6	b. van veen	PERSON
admet-1437	626	7	j. kiesvaara	PERSON
admet-1437	626	8	j. hirvonen	PERSON
admet-1437	626	9	l. peltonen	PERSON
admet-1437	626	10	t. laaksonen	PERSON
admet-1437	628	1	14 (2013	DATE
admet-1437	628	2	748	CARDINAL
admet-1437	630	1	32	CARDINAL
admet-1437	630	2	c. konnerth	PERSON
admet-1437	630	3	w peukert	PERSON
admet-1437	630	4	g. lee	PERSON
admet-1437	631	1	international journal of pharmaceutics	ORG
admet-1437	631	2	554	CARDINAL
admet-1437	631	3	2019	CARDINAL
admet-1437	631	4	54-60	CARDINAL
admet-1437	633	1	33	CARDINAL
admet-1437	633	2	d.	NORP
admet-1437	633	3	j. rosenberg	PERSON
admet-1437	633	4	a. bauer-brandl	PERSON
admet-1437	633	5	m. brandl	PERSON
admet-1437	635	1	european journal of pharmaceutical sciences	ORG
admet-1437	635	2	96	CARDINAL
admet-1437	635	3	2017	CARDINAL
admet-1437	635	4	20	CARDINAL
admet-1437	637	1	34	CARDINAL
admet-1437	637	2	k. tsinman	PERSON
admet-1437	637	3	o. tsinman	PERSON
admet-1437	637	4	r. lingamaneni	PERSON
admet-1437	637	5	s. zhu	PERSON
admet-1437	637	6	b. riebesehl	PERSON
admet-1437	637	7	a. grandeury	PERSON
admet-1437	637	8	m. juhnke	PERSON
admet-1437	637	9	b. van eerdenbrugh	PERSON
admet-1437	639	1	35	CARDINAL
admet-1437	639	2	2018	DATE
admet-1437	639	3	161	CARDINAL
admet-1437	640	1	35	CARDINAL
admet-1437	640	2	j. li	PERSON
admet-1437	640	3	li	PERSON
admet-1437	640	4	n. nessah	PERSON
admet-1437	640	5	y. huang	PERSON
admet-1437	640	6	c. hidalgo	PERSON
admet-1437	640	7	a. owen	PERSON
admet-1437	640	8	i.j. hidalgo	PERSON
admet-1437	641	1	2	CARDINAL
admet-1437	641	2	108	CARDINAL
admet-1437	641	3	2019	CARDINAL
admet-1437	644	1	bonhoeffer et al. admet	PERSON
admet-1437	644	2	2022	CARDINAL
admet-1437	644	3	253	CARDINAL
admet-1437	645	1	36	CARDINAL
admet-1437	645	2	m. imono	PERSON
admet-1437	645	3	h. uchiyama	PERSON
admet-1437	645	4	h. ueda	PERSON
admet-1437	645	5	k. kadota	PERSON
admet-1437	646	1	second	ORDINAL
admet-1437	647	1	international journal of pharmaceutics	ORG
admet-1437	647	2	558	CARDINAL
admet-1437	647	3	2019) 242249	DATE
admet-1437	649	1	37	CARDINAL
admet-1437	649	2	arce	ORG
admet-1437	649	3	n. setiawan	PERSON
admet-1437	649	4	campbell	ORG
admet-1437	649	5	x. lu	PERSON
admet-1437	649	6	m.j. nethercott	PERSON
admet-1437	649	7	y. su	PERSON
admet-1437	651	1	17	CARDINAL
admet-1437	651	2	4125-4140	CARDINAL
admet-1437	653	1	38	CARDINAL
admet-1437	653	2	h. tian	PERSON
admet-1437	653	3	z. qin	PERSON
admet-1437	653	4	g. wang	PERSON
admet-1437	653	5	x. yu	PERSON
admet-1437	653	6	j. chen	PERSON
admet-1437	653	7	z. lin	PERSON
admet-1437	653	8	s. du	PERSON
admet-1437	653	9	h. yin, h. zou	PERSON
admet-1437	653	10	t. liu.	PERSON
admet-1437	655	1	392	CARDINAL
admet-1437	655	2	2021	CARDINAL
admet-1437	655	3	179	CARDINAL
admet-1437	657	1	39	CARDINAL
admet-1437	657	2	d.e.	GPE
admet-1437	657	3	moseson	ORG
admet-1437	657	4	j. brouwers	PERSON
admet-1437	657	5	p. augustijns	PERSON
admet-1437	657	6	l.s. taylor	PERSON
admet-1437	658	1	16	CARDINAL
admet-1437	658	2	2019	CARDINAL
admet-1437	660	1	40	CARDINAL
admet-1437	660	2	d. jünemann	PERSON
admet-1437	660	3	j. dressman	PERSON
admet-1437	662	1	64	CARDINAL
admet-1437	662	2	2012	DATE
admet-1437	662	3	931	CARDINAL
admet-1437	664	1	41	CARDINAL
admet-1437	664	2	k. anhalt	PERSON
admet-1437	664	3	s. geissler	PERSON
admet-1437	664	4	m. harms	PERSON
admet-1437	664	5	m. weigandt	PERSON
admet-1437	664	6	g. fricker	PERSON
admet-1437	666	1	29	CARDINAL
admet-1437	666	2	2012	DATE
admet-1437	666	3	2887	CARDINAL
admet-1437	668	1	42	CARDINAL
admet-1437	668	2	b. van eerdenbrugh	PERSON
admet-1437	668	3	d.e.	GPE
admet-1437	668	4	alonzo	GPE
admet-1437	668	5	l.s. taylor	PERSON
admet-1437	669	1	28	CARDINAL
admet-1437	669	2	2011	DATE
admet-1437	669	3	1643	CARDINAL
admet-1437	671	1	43	CARDINAL
admet-1437	671	2	b. van eerdenbrugh	PERSON
admet-1437	671	3	j. vermant	PERSON
admet-1437	671	4	j.a. martens	PERSON
admet-1437	671	5	l. froyen	PERSON
admet-1437	671	6	j. van humbeeck	PERSON
admet-1437	671	7	g. van den mooter	PERSON
admet-1437	671	8	p. augustijns	PERSON
admet-1437	673	1	7 (2010) 1858-1870	DATE
admet-1437	675	1	44	CARDINAL
admet-1437	675	2	s.b.	GPE
admet-1437	675	3	d.a. shah	PERSON
admet-1437	675	4	r.h. dave.	PERSON
admet-1437	677	1	104	CARDINAL
admet-1437	677	2	2015	CARDINAL
admet-1437	677	3	2094	CARDINAL
admet-1437	678	1	https://doi.org/10.1002/jps.24426	ORG
admet-1437	679	1	45	CARDINAL
admet-1437	679	2	m. colombo	PERSON
admet-1437	679	3	s. staufenbiel	PERSON
admet-1437	679	4	e. rühl	PERSON
admet-1437	679	5	r. bodmeier	PERSON
admet-1437	681	1	international journal of pharmaceutics	ORG
admet-1437	681	2	521	CARDINAL
admet-1437	681	3	2017	CARDINAL
admet-1437	681	4	156	CARDINAL
admet-1437	683	1	46	CARDINAL
admet-1437	683	2	m. colombo	PERSON
admet-1437	683	3	c. minussi	PERSON
admet-1437	683	4	s. orthmann	PERSON
admet-1437	683	5	s. staufenbiel	PERSON
admet-1437	683	6	r. bodmeier	PERSON
admet-1437	685	1	european journal of pharmaceutics	ORG
admet-1437	685	2	biopharmaceutics	ORG
admet-1437	685	3	125	CARDINAL
admet-1437	685	4	2018	DATE
admet-1437	685	5	159	CARDINAL
admet-1437	686	1	https://doi.org/10.1016/j.ejpb.2018.01.013	PERSON
admet-1437	687	1	47	CARDINAL
admet-1437	687	2	m.e.	PERSON
admet-1437	687	3	k.c. johnson	PERSON
admet-1437	689	1	10	CARDINAL
admet-1437	689	2	1308-1314	DATE
admet-1437	691	1	48	CARDINAL
admet-1437	691	2	j. wang	PERSON
admet-1437	691	3	d.r. flanagan	PERSON
admet-1437	693	1	1	CARDINAL
admet-1437	694	1	1999	DATE
admet-1437	694	2	731	CARDINAL
admet-1437	696	1	49	CARDINAL
admet-1437	696	2	j. wang	PERSON
admet-1437	696	3	d.r. flanagan	PERSON
admet-1437	697	1	2	CARDINAL
admet-1437	698	1	journal of pharmaceutical sciences	ORG
admet-1437	698	2	91 (2002	DATE
admet-1437	698	3	534	CARDINAL
admet-1437	699	1	https://doi.org/10.1002/jps.10039	NORP
admet-1437	700	1	50	CARDINAL
admet-1437	700	2	y. wang	PERSON
admet-1437	700	3	b. abrahamsson	PERSON
admet-1437	700	4	l. lindfors	PERSON
admet-1437	700	5	j.g.brasseur	PERSON
admet-1437	702	1	104	CARDINAL
admet-1437	702	2	2015	CARDINAL
admet-1437	702	3	2998-3017	CARDINAL
admet-1437	704	1	51	CARDINAL
admet-1437	704	2	m. abrami	PERSON
admet-1437	704	3	l. grassi	PERSON
admet-1437	704	4	r. di vittorio	PERSON
admet-1437	704	5	d. hasa	PERSON
admet-1437	704	6	d. voinovich	PERSON
admet-1437	704	7	g. grassi	PERSON
admet-1437	704	8	i. colombo	PERSON
admet-1437	704	9	m. grassi	PERSON
admet-1437	706	1	2022	CARDINAL
admet-1437	706	2	253	CARDINAL
admet-1437	706	3	285	CARDINAL
admet-1437	707	1	8	CARDINAL
admet-1437	707	2	2020	DATE
admet-1437	707	3	297	CARDINAL
admet-1437	708	1	52	CARDINAL
admet-1437	708	2	y. gao	PERSON
admet-1437	708	3	b. glennon	PERSON
admet-1437	710	1	6	CARDINAL
admet-1437	712	1	53	CARDINAL
admet-1437	712	2	garcía	GPE
admet-1437	712	3	m. thommes.	PERSON
admet-1437	714	1	257	CARDINAL
admet-1437	714	2	2014	DATE
admet-1437	714	3	120	CARDINAL
admet-1437	715	1	54	CARDINAL
admet-1437	715	2	johnson	PERSON
admet-1437	717	1	101	CARDINAL
admet-1437	717	2	2012	DATE
admet-1437	717	3	681	CARDINAL
admet-1437	719	1	55	CARDINAL
admet-1437	719	2	a. koswara	PERSON
admet-1437	719	3	h.h.tung	GPE
admet-1437	719	4	s. bordawekar	PERSON
admet-1437	719	5	z.k. nagy	GPE
admet-1437	719	6	d. ramkrishna	GPE
admet-1437	720	1	nanocrystal	ORG
admet-1437	721	1	14	DATE
admet-1437	721	2	2017	CARDINAL
admet-1437	721	3	1023-1032	DATE
admet-1437	723	1	56	CARDINAL
admet-1437	723	2	owens	PERSON
admet-1437	723	3	r.c.	PERSON
admet-1437	723	4	wendt	GPE
admet-1437	725	1	13	CARDINAL
admet-1437	725	2	1969	DATE
admet-1437	727	1	57	CARDINAL
admet-1437	729	1	66	CARDINAL
admet-1437	729	2	1970	DATE
admet-1437	729	3	66-81	CARDINAL
admet-1437	731	1	58	CARDINAL
admet-1437	731	2	dorris	PERSON
admet-1437	731	3	d.g.	GPE
admet-1437	732	1	zero	CARDINAL
admet-1437	733	1	1980	DATE
admet-1437	733	2	353	CARDINAL
admet-1437	735	1	59	CARDINAL
admet-1437	735	2	13320:2020	CARDINAL
admet-1437	735	3	2020	DATE
admet-1437	736	1	60	CARDINAL
admet-1437	736	2	iso 22412:2008	PERSON
admet-1437	736	3	2008	DATE
admet-1437	737	1	61	CARDINAL
admet-1437	737	2	iso 489:2022	ORG
admet-1437	737	3	2022	CARDINAL
admet-1437	738	1	62	CARDINAL
admet-1437	738	2	noyes	ORG
admet-1437	738	3	w.r. whitney	GPE
admet-1437	739	1	american	NORP
admet-1437	739	2	930	CARDINAL
admet-1437	741	1	63	CARDINAL
admet-1437	741	2	w. nernst	PERSON
admet-1437	742	1	theorie der reaktionsgeschwindigkeit	PERSON
admet-1437	742	2	heterogenen systemen	ORG
admet-1437	743	1	zeitschrift für	PERSON
admet-1437	743	2	47	CARDINAL
admet-1437	743	3	1904	DATE
admet-1437	743	4	52	CARDINAL
admet-1437	744	1	https://doi.org/10.1515/zpch-1904-4704	ORG
admet-1437	745	1	64	CARDINAL
admet-1437	746	1	verhandlungen des dritten	ORG
admet-1437	746	2	heidelberg	GPE
admet-1437	746	3	1904	DATE
admet-1437	746	4	8	CARDINAL
admet-1437	746	5	bis 14	ORG
admet-1437	747	1	august 1904	DATE
admet-1437	748	1	b.g.	GPE
admet-1437	748	2	leipzig	GPE
admet-1437	748	3	germany	GPE
admet-1437	748	4	1905	DATE
admet-1437	748	5	484	CARDINAL
admet-1437	749	1	65	CARDINAL
admet-1437	749	2	m. bisrat	PERSON
admet-1437	749	3	c. nyström	PERSON
admet-1437	753	1	international journal of pharmaceutics	ORG
admet-1437	753	2	47	CARDINAL
admet-1437	753	3	1988	DATE
admet-1437	753	4	223	CARDINAL
admet-1437	755	1	66	CARDINAL
admet-1437	755	2	g. milosovich	PERSON
admet-1437	759	1	journal of pharmaceutical sciences	ORG
admet-1437	759	2	52	DATE
admet-1437	759	3	1963	DATE
admet-1437	759	4	236	CARDINAL
admet-1437	761	1	67	CARDINAL
admet-1437	761	2	w.i. higuchi	PERSON
admet-1437	761	3	e.n.	GPE
admet-1437	763	1	i.	PERSON
admet-1437	764	1	52	DATE
admet-1437	764	2	1963	DATE
admet-1437	764	3	67	CARDINAL
admet-1437	766	1	68	CARDINAL
admet-1437	766	2	hintz	PERSON
admet-1437	766	3	k.c. johnson	PERSON
admet-1437	768	1	international journal of pharmaceutics	ORG
admet-1437	768	2	51	CARDINAL
admet-1437	768	3	1989	DATE
admet-1437	768	4	9	CARDINAL
admet-1437	770	1	69	CARDINAL
admet-1437	771	1	micron	CARDINAL
admet-1437	772	1	international journal of pharmaceutics	ORG
admet-1437	772	2	313	CARDINAL
admet-1437	772	3	2006	DATE
admet-1437	772	4	114	CARDINAL
admet-1437	774	1	70	CARDINAL
admet-1437	774	2	k. sugano	PERSON
admet-1437	776	1	international journal of pharmaceutics	ORG
admet-1437	776	2	363	CARDINAL
admet-1437	776	3	2008) 7377	DATE
admet-1437	777	1	https://doi.org/10.1016/j.ijpharm.2008.07.002	ORG
admet-1437	778	1	https://doi.org/10.1021/acsomega.0c05558 https://doi.org/10.1016/j.powtec.2014.01.095 https://doi.org/10.1016/j.powtec.2014.01.095	FAC
admet-1437	778	2	https://doi.org/10.1515/zpch-1904-4704	ORG
admet-1437	778	3	https://doi.org/10.1002/jps.2600520310 https://doi.org/10.1002/jps.2600520114 https://doi.org/10.1016/0378-5173(89)90069-0 https://doi.org/10.1016/0378-5173(89)90069-0	PERSON
admet-1437	778	4	bonhoeffer et al	PERSON
admet-1437	778	5	2022	CARDINAL
admet-1437	779	1	253	CARDINAL
admet-1437	779	2	71	CARDINAL
admet-1437	779	3	m. jonsson	PERSON
admet-1437	779	4	e. weibull	PERSON
admet-1437	779	5	b. abrahamson	PERSON
admet-1437	781	1	104	CARDINAL
admet-1437	781	2	2015	CARDINAL
admet-1437	781	3	2969	CARDINAL
admet-1437	783	1	72	CARDINAL
admet-1437	783	2	l.f. knapp	PERSON
admet-1437	785	1	457	CARDINAL
admet-1437	787	1	73	CARDINAL
admet-1437	788	1	r.l.	PERSON
admet-1437	788	2	g.l. amidon	PERSON
admet-1437	790	1	10	CARDINAL
admet-1437	790	2	1993	DATE
admet-1437	790	3	264	CARDINAL
admet-1437	792	1	74	CARDINAL
admet-1437	792	2	e. lipka	PERSON
admet-1437	792	3	j.r. crison	PERSON
admet-1437	792	4	g.l. amidon	PERSON
admet-1437	794	1	19	CARDINAL
admet-1437	794	2	359	CARDINAL
admet-1437	796	1	75	CARDINAL
admet-1437	796	2	j.b. dressman	PERSON
admet-1437	797	1	biopharmaceutics	ORG
admet-1437	798	1	journal of pharmaceutical sciences	ORG
admet-1437	798	2	99	CARDINAL
admet-1437	798	3	2010	DATE
admet-1437	800	1	76	CARDINAL
admet-1437	800	2	f. broccatelli	PERSON
admet-1437	802	1	13 (2011) 519547	DATE
admet-1437	804	1	77	CARDINAL
admet-1437	804	2	p. daublain	PERSON
admet-1437	804	3	f. kesisoglou	PERSON
admet-1437	804	4	a. templeton	PERSON
admet-1437	804	5	c. mcgregor	PERSON
admet-1437	806	1	12	CARDINAL
admet-1437	806	2	2015	CARDINAL
admet-1437	806	3	1039	CARDINAL
admet-1437	808	1	78	CARDINAL
admet-1437	808	2	k. sugano	PERSON
admet-1437	808	3	k. terada	PERSON
admet-1437	810	1	104	CARDINAL
admet-1437	810	2	2015	CARDINAL
admet-1437	810	3	2777-2788	CARDINAL
admet-1437	812	1	79	CARDINAL
admet-1437	812	2	j. rosenberger	PERSON
admet-1437	812	3	j. butler	PERSON
admet-1437	812	4	j. dressman	PERSON
admet-1437	814	1	107	CARDINAL
admet-1437	814	2	2018	DATE
admet-1437	816	1	80	CARDINAL
admet-1437	816	2	wuelfing, a. el marrouni	PERSON
admet-1437	816	3	m.p. lipert	PERSON
admet-1437	816	4	p. daublain	PERSON
admet-1437	816	5	f. kesisoglou	PERSON
admet-1437	816	6	a. converso	PERSON
admet-1437	816	7	a.c. templeton	GPE
admet-1437	817	1	discovery	PRODUCT
admet-1437	818	1	journal of medicinal chemistry	ORG
admet-1437	818	2	65	CARDINAL
admet-1437	818	3	2022	CARDINAL
admet-1437	820	1	81	CARDINAL
admet-1437	820	2	c. konnerth	PERSON
admet-1437	820	3	f. flach	PERSON
admet-1437	820	4	s. breitung-faes	PERSON
admet-1437	820	5	j. schmidt	PERSON
admet-1437	820	6	a. kwade	PERSON
admet-1437	820	7	w. peukert	PERSON
admet-1437	822	1	294	CARDINAL
admet-1437	822	2	2016	CARDINAL
admet-1437	822	3	71	CARDINAL
admet-1437	824	1	82	CARDINAL
admet-1437	824	2	c.j. strachan	PERSON
admet-1437	826	1	international journal of pharmaceutics	ORG
admet-1437	826	2	586	CARDINAL
admet-1437	826	3	2020) 119492	DATE
admet-1437	828	1	83	CARDINAL
admet-1437	828	2	j. jinno	PERSON
admet-1437	828	3	n. kamada	PERSON
admet-1437	828	4	m. miyake	PERSON
admet-1437	828	5	k. yamada	PERSON
admet-1437	828	6	t. mukai	ORG
admet-1437	828	7	m. odomi	PERSON
admet-1437	828	8	h. toguchi	PERSON
admet-1437	828	9	g.g. liversidge	GPE
admet-1437	828	10	k. higaki	PERSON
admet-1437	828	11	t. kimura	PERSON
admet-1437	830	1	111	CARDINAL
admet-1437	830	2	2006	DATE
admet-1437	830	3	56	CARDINAL
admet-1437	832	1	84	CARDINAL
admet-1437	832	2	m. koziolek	PERSON
admet-1437	832	3	m. grimm	PERSON
admet-1437	832	4	f. schneider	PERSON
admet-1437	832	5	m. sager	PERSON
admet-1437	832	6	j.p. kühn	PERSON
admet-1437	832	7	w. siegmund	PERSON
admet-1437	832	8	w. weitschies	PERSON
admet-1437	834	1	101	CARDINAL
admet-1437	834	2	2016	CARDINAL
admet-1437	834	3	75-88	DATE
admet-1437	836	1	85	CARDINAL
admet-1437	836	2	m. vertzoni	PERSON
admet-1437	836	3	p. augustijns	PERSON
admet-1437	836	4	m. grimm	PERSON
admet-1437	836	5	m. koziolek	PERSON
admet-1437	836	6	g. lemmens	PERSON
admet-1437	836	7	n. parrott	PERSON
admet-1437	836	8	c. reppas	PERSON
admet-1437	836	9	j. rubbens	PERSON
admet-1437	836	10	j. van den	PERSON
admet-1437	836	11	w. weitschies	PERSON
admet-1437	836	12	c.g. wilson	PERSON
admet-1437	838	1	european journal of pharmaceutical sciences	ORG
admet-1437	838	2	134	CARDINAL
admet-1437	838	3	2019	CARDINAL
admet-1437	838	4	153	CARDINAL
admet-1437	840	1	86	CARDINAL
admet-1437	840	2	z. vinarov	PERSON
admet-1437	840	3	m. abdallah	PERSON
admet-1437	840	4	agundez	PERSON
admet-1437	840	5	k. allegaert	PERSON
admet-1437	840	6	a.w. basit	PERSON
admet-1437	840	7	m. braeckmans	PERSON
admet-1437	840	8	j. ceulemans	PERSON
admet-1437	840	9	m. corsetti	PERSON
admet-1437	840	10	b.t. griffin	PERSON
admet-1437	840	11	m. grimm	PERSON
admet-1437	840	12	d. keszthelyi	PERSON
admet-1437	840	13	m. koziolek	PERSON
admet-1437	840	14	c.m.	GPE
admet-1437	840	15	c. matthys	PERSON
admet-1437	840	16	l.e. mccoubrey	ORG
admet-1437	840	17	a. mitra	PERSON
admet-1437	840	18	c. reppas	PERSON
admet-1437	840	19	j. stappaerts	PERSON
admet-1437	840	20	n.l.	GPE
admet-1437	840	21	m. vertzoni	PERSON
admet-1437	840	22	w. weitschies	PERSON
admet-1437	840	23	c. wilson	PERSON
admet-1437	840	24	p. augustijns	PERSON
admet-1437	841	1	2022	CARDINAL
admet-1437	841	2	253	CARDINAL
admet-1437	841	3	287	CARDINAL
admet-1437	842	1	european journal of pharmaceutical sciences	ORG
admet-1437	842	2	162	CARDINAL
admet-1437	842	3	2021	CARDINAL
admet-1437	842	4	105812	DATE
admet-1437	844	1	87	CARDINAL
admet-1437	844	2	j. brouwers	PERSON
admet-1437	844	3	m.e. brewster	ORG
admet-1437	844	4	p. augustijns	PERSON
admet-1437	845	1	supersaturating drug delivery systems	ORG
admet-1437	846	1	98	CARDINAL
admet-1437	846	2	2009	DATE
admet-1437	846	3	2549	CARDINAL
admet-1437	848	1	88	CARDINAL
admet-1437	848	2	taylor	PERSON
admet-1437	849	1	zhang	PERSON
admet-1437	851	1	101	CARDINAL
admet-1437	851	2	2016	CARDINAL
admet-1437	851	3	122	CARDINAL
admet-1437	853	1	89	CARDINAL
admet-1437	853	2	boyd	GPE
admet-1437	853	3	z. vinarov	PERSON
admet-1437	853	4	m. kuentz	PERSON
admet-1437	853	5	j. brouwers	PERSON
admet-1437	853	6	p. augustijns	PERSON
admet-1437	853	7	m. brandl	PERSON
admet-1437	853	8	a. bernkopschnürch	PERSON
admet-1437	853	9	n. shrestha	PERSON
admet-1437	853	10	a. müllertz	PERSON
admet-1437	853	11	a. bauer-brandl	PERSON
admet-1437	853	12	jannin	PERSON
admet-1437	855	1	european journal of pharmaceutical sciences	ORG
admet-1437	855	2	137	CARDINAL
admet-1437	855	3	2019) 104967	DATE
admet-1437	857	1	90	CARDINAL
admet-1437	857	2	z. vinarov	PERSON
admet-1437	857	3	b. abrahamsson	PERSON
admet-1437	857	4	p. artursson	PERSON
admet-1437	857	5	h. batchelor	PERSON
admet-1437	857	6	a. bernkop-schnürch	PERSON
admet-1437	857	7	j. butler	PERSON
admet-1437	857	8	j. ceulemans	PERSON
admet-1437	857	9	n. davies	PERSON
admet-1437	857	10	d. dupont	PERSON
admet-1437	857	11	g. eide flaten	PERSON
admet-1437	857	12	b.t. griffin	PERSON
admet-1437	857	13	v. jannin	PERSON
admet-1437	857	14	j. keemink	PERSON
admet-1437	857	15	f. kesisoglou	PERSON
admet-1437	857	16	m. koziolek	PERSON
admet-1437	857	17	m. kuentz	PERSON
admet-1437	857	18	a. mackie	PERSON
admet-1437	857	19	a.j. meléndez-martínez	PERSON
admet-1437	857	20	m. mcallister	PERSON
admet-1437	857	21	a. müllertz	PERSON
admet-1437	857	22	c.m. o'driscoll	PERSON
admet-1437	857	23	n. parrott	PERSON
admet-1437	857	24	j. paszkowska	PERSON
admet-1437	857	25	c. reppas	PERSON
admet-1437	857	26	c. stillhart	PERSON
admet-1437	857	27	k. sugano	PERSON
admet-1437	857	28	e. toader	PERSON
admet-1437	857	29	k. valentová	PERSON
admet-1437	857	30	m. vertzoni	PERSON
admet-1437	857	31	c.g. wilson	PERSON
admet-1437	857	32	p. augustijns	PERSON
admet-1437	859	1	171	CARDINAL
admet-1437	859	2	2021	CARDINAL
admet-1437	859	3	289	CARDINAL
admet-1437	861	1	2022	CARDINAL
admet-1437	861	2	iapc	ORG
admet-1437	861	3	zagreb	GPE
admet-1437	861	4	croatia	GPE
admet-1437	862	1	http://creativecommons.org/licenses/by/3.0/	ORG